4 EVENTS IN ONE:Developing and Demonstrating „value“ for Speciality Pharma Market AccessAchieving Market Access for High-Value Oncology & Specialty TherapeuticsBiosimilar Market Access & CommercializationManaged Entry Agreements Workshop This year’s “Spring Edition” in Brussels, will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible.  This is THE “must attend” event for senior representatives of the market access community in Europe. With over 30 senior-level speakers from Payers, HTAs, Hospitals, stakeholder groups, and not to mention the pharmaceutical industry. Attendees will achieve the most relevant insights,  benchmarking and networking experience available for senior executives who are involved in patient access, health economics, outcomes, pricing and reimbursement.